Noel Rappin Writes Here

Tag: podcasts

May 26, 2010: Answer The Question Please

Top Story Got interviewed yesterday by Miles Forrest and Curtis McHale of the coderpath podcast. Presumably it’ll be out and public in the next couple of weeks. You’ll be the first person I tell. Couple things It’s been a while since I did anything like this, and I always forget how much it’s a genuine skill to be able to give a clear answer without doing a lot of ums and ahs.

May 25, 2010: Betas

Top Story Beta 3 should be out today. The main change in this Beta is the inclusion of the Cucumber chapter, which has been updated both in terms of new tech, and also in terms of conclusions about how to use Cucumber. And In Rails news… When last we met, Rails 2.3.6 had just been released. Well, in the intervening 24 hours, we’ve bumped all the way to 2.3.8, with two bug fix releases, explained by Jeremy Kemper here and here.

May 3, 2010: Hi, I'm Back

Hey, where were you? Sorry about that, I spent most of last week running the Obtiva Ruby/Rails/TDD 4-day boot camp training, and I didn’t have time to do this daily catchup. Hey, if you think you need me or somebody like me to come to your company and blather about Ruby and Rails for a few days, contact us at http://www.obtiva.com. It’s fun. Book Status Rails test prescriptions: still on sale.

April 21, 2010: Annnndd... We're live

Top Story What else, but the actual live sale page for Rails Test Prescriptions, which is http://www.pragprog.com/titles/nrtest/rails-test-prescriptions. You should be able to see the cover off to the right sidebar. (As I write this, they haven’t turned on the “Buy” link, sometime today, I think). I like the mortar and pestle in the cover, it has a nice resonance with “prescriptions” and also, at least for me, a little bit of a tinkering kind of vibe.



Copyright 2024 Noel Rappin

All opinions and thoughts expressed or shared in this article or post are my own and are independent of and should not be attributed to my current employer, Chime Financial, Inc., or its subsidiaries.